BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27088546)

  • 1. Coordinated induction of cell survival signaling in the inflamed microenvironment of the prostate.
    McIlwain DW; Zoetemelk M; Myers JD; Edwards MT; Snider BM; Jerde TJ
    Prostate; 2016 Jun; 76(8):722-34. PubMed ID: 27088546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-apoptotic tumor necrosis factor-alpha transduction pathway in normal prostate, benign prostatic hyperplasia and prostatic carcinoma.
    Ricote M; Royuela M; García-Tuñón I; Bethencourt FR; Paniagua R; Fraile B
    J Urol; 2003 Sep; 170(3):787-90. PubMed ID: 12913698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
    Ray S; Almasan A
    Cancer Res; 2003 Aug; 63(15):4713-23. PubMed ID: 12907654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression.
    Simons BW; Durham NM; Bruno TC; Grosso JF; Schaeffer AJ; Ross AE; Hurley PJ; Berman DM; Drake CG; Thumbikat P; Schaeffer EM
    J Pathol; 2015 Feb; 235(3):478-89. PubMed ID: 25348195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of prostate epithelial progenitor cells after inflammation of the mouse prostate.
    Wang L; Zoetemelk M; Chitteti BR; Ratliff TL; Myers JD; Srour EF; Broxmeyer H; Jerde TJ
    Am J Physiol Renal Physiol; 2015 Jun; 308(12):F1421-30. PubMed ID: 25925259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasome inhibition blocks caspase-8 degradation and sensitizes prostate cancer cells to death receptor-mediated apoptosis.
    Thorpe JA; Christian PA; Schwarze SR
    Prostate; 2008 Feb; 68(2):200-9. PubMed ID: 18076022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms.
    Shankar S; Singh TR; Srivastava RK
    Prostate; 2004 Sep; 61(1):35-49. PubMed ID: 15287092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins.
    Tang DG; Li L; Chopra DP; Porter AT
    Cancer Res; 1998 Aug; 58(15):3466-79. PubMed ID: 9699682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile of cell proliferation and apoptosis activated by the intrinsic and extrinsic pathways in the prostate of aging rats.
    Gonzaga ACR; Campolina-Silva GH; Werneck-Gomes H; Moura-Cordeiro JD; Santos LC; Mahecha GAB; Morais-Santos M; Oliveira CA
    Prostate; 2017 Jun; 77(9):937-948. PubMed ID: 28480526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
    Song JH; Bellail A; Tse MC; Yong VW; Hao C
    J Neurosci; 2006 Mar; 26(12):3299-308. PubMed ID: 16554480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of benign prostatic hyperplasia is associated with pro-inflammatory mediators and chronic activation of prostate-infiltrating lymphocytes.
    Norström MM; Rådestad E; Sundberg B; Mattsson J; Henningsohn L; Levitsky V; Uhlin M
    Oncotarget; 2016 Apr; 7(17):23581-93. PubMed ID: 26993768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression.
    Huerta-Yepez S; Vega M; Jazirehi A; Garban H; Hongo F; Cheng G; Bonavida B
    Oncogene; 2004 Jun; 23(29):4993-5003. PubMed ID: 15048072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tocotrienol-induced caspase-8 activation is unrelated to death receptor apoptotic signaling in neoplastic mammary epithelial cells.
    Shah S; Sylvester PW
    Exp Biol Med (Maywood); 2004 Sep; 229(8):745-55. PubMed ID: 15337828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
    Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
    Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
    Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
    Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-epi-Sinuleptolide induces cell cycle arrest and apoptosis through tumor necrosis factor/mitochondria-mediated caspase signaling pathway in human skin cancer cells.
    Liang CH; Wang GH; Chou TH; Wang SH; Lin RJ; Chan LP; So EC; Sheu JH
    Biochim Biophys Acta; 2012 Jul; 1820(7):1149-57. PubMed ID: 22348919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auriculasin sensitizes primary prostate cancer cells to TRAIL-mediated apoptosis through up-regulation of the DR5-dependent pathway.
    Cho HD; Gu IA; Won YS; Moon KD; Park KH; Seo KI
    Food Chem Toxicol; 2019 Apr; 126():223-232. PubMed ID: 30817944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitor of Apoptosis Protein-1 Regulates Tumor Necrosis Factor-Mediated Destruction of Intestinal Epithelial Cells.
    Grabinger T; Bode KJ; Demgenski J; Seitz C; Delgado ME; Kostadinova F; Reinhold C; Etemadi N; Wilhelm S; Schweinlin M; Hänggi K; Knop J; Hauck C; Walles H; Silke J; Wajant H; Nachbur U; W Wei-Lynn W; Brunner T
    Gastroenterology; 2017 Mar; 152(4):867-879. PubMed ID: 27889570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
    Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
    J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.
    Shariat SF; Ashfaq R; Roehrborn CG; Slawin KM; Lotan Y
    J Urol; 2005 Nov; 174(5):2046-50. PubMed ID: 16217391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.